Results 251 to 260 of about 68,288 (264)
Some of the next articles are maybe not open access.
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.
The Lancet, 2010 M. Audeh, J. Carmichael, R. Penson, M. Friedlander, B. Powell, K. Bell-McGuinn, C. Scott, J. Weitzel, A. Oaknin, N. Loman, K. Lu, R. Schmutzler, U. Matulonis, M. Wickens, A. Tutt +14 moresemanticscholar +1 more sourceLocalization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.
Science, 1994 R. Wooster, S. Neuhausen, J. Mangion, Y. Quirk, D. Ford, N. Collins, K. Nguyen, S. Seal, T. Tran, D. Averill +9 moresemanticscholar +1 more sourceBRCA1 and BRCA2
2013 Stephan Mose, Stephan Mose, Brandon J. Fisher, Iris Rusu, Charlie Ma, Lu Wang, Larry C. Daugherty, Brandon J. Fisher, Stephan Mose, Tod W. Speer, Tod W. Speer, Anthony E. Dragun, Rene Rubin, Claudia Rübe, James H. Brashears, Stephan Mose, James H. Brashears, Christian Weiss, Claus Roedel, Christian Weiss, Claus Roedel, Edward J. Gracely, Rene Rubin, Lindsay G. Jensen, Brent S. Rose, Loren K. Mell, Arno J. Mundt, Iris Rusu, Anthony E. Dragun, Anthony E. Dragun, Albert S. DeNittis, Christin A. Knowlton, Michelle Kolton Mackay, Yan Yu, Laura Doyle, Cheng B. Saw, Yan Yu, Laura Doyle, Ning J. Yue, Rene Rubin, Nisha R. Patel, Michael L. Wong, Brian F. Hasson, Daniel Yeung, Jatinder Palta, Christin A. Knowlton, Michelle Kolton Mackay, James H. Brashears, Anthony E. Dragun, Anthony E. Dragun, David E. Wazer, Anthony E. Dragun, Anthony E. Dragun, Stephan Mose, Susan M. Varnum, Marianne B. Sowa, William F. Morgan +56 moreopenaire +2 more sources
